SignatureFD’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.93M | Buy |
97,795
+1,948
| +2% | +$114K | 0.09% | 80 |
|
|
2025
Q4 | $5.17M | Buy |
95,847
+857
| +0.9% | +$41.2K | 0.08% | 90 |
|
|
2025
Q3 | $4.28M | Sell |
94,990
-4,605
| -5% | -$215K | 0.07% | 103 |
|
|
2025
Q2 | $4.61M | Sell |
99,595
-6,418
| -6% | -$315K | 0.08% | 88 |
|
|
2025
Q1 | $6.47M | Buy |
106,013
+3,230
| +3% | +$188K | 0.12% | 58 |
|
|
2024
Q4 | $5.81M | Buy |
102,783
+3,609
| +4% | +$202K | 0.11% | 61 |
|
|
2024
Q3 | $5.13M | Buy |
99,174
+7,799
| +9% | +$366K | 0.1% | 67 |
|
|
2024
Q2 | $3.79M | Sell |
91,375
-7,231
| -7% | -$324K | 0.08% | 91 |
|
|
2024
Q1 | $5.35M | Sell |
98,606
-3,899
| -4% | -$199K | 0.11% | 63 |
|
|
2023
Q4 | $5.26M | Sell |
102,505
-3,481
| -3% | -$183K | 0.12% | 62 |
|
|
2023
Q3 | $6.15M | Buy |
105,986
+564
| +0.5% | +$34.6K | 0.16% | 52 |
|
|
2023
Q2 | $6.74M | Sell |
105,422
-1,339
| -1% | -$89.8K | 0.17% | 46 |
|
|
2023
Q1 | $7.4M | Buy |
106,761
+59,528
| +126% | +$4.2M | 0.2% | 43 |
|
|
2022
Q4 | $3.4M | Buy |
47,233
+2,650
| +6% | +$200K | 0.1% | 69 |
|
|
2022
Q3 | $3.17M | Buy |
44,583
+926
| +2% | +$67.2K | 0.11% | 65 |
|
|
2022
Q2 | $3.36M | Buy |
43,657
+1,280
| +3% | +$97.5K | 0.11% | 62 |
|
|
2022
Q1 | $3.1M | Buy |
42,377
+5,174
| +14% | +$347K | 0.09% | 68 |
|
|
2021
Q4 | $2.32M | Buy |
37,203
+1,512
| +4% | +$88.7K | 0.07% | 98 |
|
|
2021
Q3 | $2.11M | Sell |
35,691
-1,502
| -4% | -$98.9K | 0.07% | 98 |
|
|
2021
Q2 | $2.48M | Buy |
37,193
+777
| +2% | +$50.7K | 0.1% | 76 |
|
|
2021
Q1 | $2.3M | Sell |
36,416
-3,643
| -9% | -$227K | 0.1% | 75 |
|
|
2020
Q4 | $2.48M | Sell |
40,059
-2,285
| -5% | -$141K | 0.12% | 66 |
|
|
2020
Q3 | $2.55M | Buy |
42,344
+7,194
| +20% | +$433K | 0.14% | 60 |
|
|
2020
Q2 | $2.07M | Buy |
35,150
+273
| +0.8% | +$16.3K | 0.12% | 63 |
|
|
2020
Q1 | $1.94M | Buy |
34,877
+381
| +1% | +$23.3K | 0.17% | 54 |
|
|
2019
Q4 | $2.21M | Buy |
34,496
+15,063
| +78% | +$863K | 0.16% | 52 |
|
|
2019
Q3 | $985K | Buy |
19,433
+2,460
| +14% | +$116K | 0.08% | 96 |
|
|
2019
Q2 | $770K | Sell |
16,973
-1,393
| -8% | -$64.9K | 0.07% | 121 |
|
|
2019
Q1 | $876K | Sell |
18,366
-139
| -0.8% | -$6.92K | 0.07% | 103 |
|
|
2018
Q4 | $962K | Sell |
18,505
-239
| -1% | -$12.8K | 0.09% | 87 |
|
|
2018
Q3 | $1.16M | Buy |
18,744
+482
| +3% | +$28.6K | 0.12% | 77 |
|
|
2018
Q2 | $1.01M | Sell |
18,262
-1,175
| -6% | -$63.5K | 0.11% | 83 |
|
|
2018
Q1 | $1.23M | Buy |
19,437
+1,208
| +7% | +$77.7K | 0.14% | 51 |
|
|
2017
Q4 | $1.12M | Buy |
18,229
+3,283
| +22% | +$205K | 0.13% | 64 |
|
|
2017
Q3 | $953K | Buy |
14,946
+1,008
| +7% | +$58.9K | 0.13% | 63 |
|
|
2017
Q2 | $777K | Buy |
13,938
+808
| +6% | +$44K | 0.11% | 63 |
|
|
2017
Q1 | $714K | Sell |
13,130
-527
| -4% | -$28.9K | 0.11% | 71 |
|
|
2016
Q4 | $798K | Buy |
13,657
+730
| +6% | +$39.9K | 0.13% | 58 |
|
|
2016
Q3 | $697K | Sell |
12,927
-140
| -1% | -$8.99K | 0.1% | 68 |
|
|
2016
Q2 | $961K | Buy |
13,067
+1,052
| +9% | +$74.3K | 0.14% | 38 |
|
|
2016
Q1 | $768K | Sell |
12,015
-222
| -2% | -$14K | 0.13% | 42 |
|
|
2015
Q4 | $842K | Buy |
12,237
+473
| +4% | +$31.3K | 0.16% | 36 |
|
|
2015
Q3 | $696K | Buy |
11,764
+2,235
| +23% | +$142K | 0.16% | 38 |
|
|
2015
Q2 | $634K | Sell |
9,529
-328
| -3% | -$21.6K | 0.14% | 47 |
|
|
2015
Q1 | $636K | Buy |
9,857
+2,026
| +26% | +$127K | 0.15% | 48 |
|
|
2014
Q4 | $462K | Buy |
7,831
+755
| +11% | +$42.6K | 0.11% | 65 |
|
|
2014
Q3 | $362K | Sell |
7,076
-48
| -0.7% | -$2.4K | 0.12% | 72 |
|
|
2014
Q2 | $346K | Sell |
7,124
-1,708
| -19% | -$84.2K | 0.12% | 78 |
|
|
2014
Q1 | $459K | Sell |
8,832
-360
| -4% | -$19.2K | 0.18% | 42 |
|
|
2013
Q4 | $489K | Buy |
9,192
+639
| +7% | +$32.6K | 0.18% | 43 |
|
|
2013
Q3 | $396K | Buy |
8,553
+1,625
| +23% | +$71.3K | 0.17% | 47 |
|
|
2013
Q2 | $310K | Buy |
+6,928
| New | +$301K | 0.16% | 62 |
|
Other funds holding BMY
VCM
VPM
SignatureFD's BMY Position: Q1 2026 in Review
SignatureFD increased its Bristol-Myers Squibb (BMY) stake by 2% in Q1 2026, buying an estimated $114K and bringing the position to 97,795 shares worth $5.93M. The position accounts for 0.09% of the portfolio, ranked #80.
SignatureFD first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.4M in Q1 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- SignatureFD held 97,795 shares of Bristol-Myers Squibb worth $5.93M as of Q1 2026.
- SignatureFD bought 1,948 Bristol-Myers Squibb shares in Q1 2026, an estimated $114K.
- Bristol-Myers Squibb made up 0.09% of SignatureFD's portfolio in Q1 2026, its #80 holding.
- SignatureFD first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- SignatureFD's Bristol-Myers Squibb position peaked at $7.4M in Q1 2023.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.